1. Home
  2. BRC vs BLTE Comparison

BRC vs BLTE Comparison

Compare BRC & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brady Corporation

BRC

Brady Corporation

HOLD

Current Price

$77.32

Market Cap

3.7B

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$148.92

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRC
BLTE
Founded
1914
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.1B
IPO Year
1984
2022

Fundamental Metrics

Financial Performance
Metric
BRC
BLTE
Price
$77.32
$148.92
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$149.00
AVG Volume (30 Days)
224.3K
244.0K
Earning Date
11-17-2025
11-10-2025
Dividend Yield
1.26%
N/A
EPS Growth
0.61
N/A
EPS
4.08
N/A
Revenue
$1,541,827,000.00
N/A
Revenue This Year
$6.76
N/A
Revenue Next Year
$3.84
N/A
P/E Ratio
$19.00
N/A
Revenue Growth
11.21
N/A
52 Week Low
$62.70
$49.00
52 Week High
$84.03
$160.55

Technical Indicators

Market Signals
Indicator
BRC
BLTE
Relative Strength Index (RSI) 50.52 68.29
Support Level $77.33 $140.07
Resistance Level $79.36 $154.00
Average True Range (ATR) 1.90 12.43
MACD -0.13 0.74
Stochastic Oscillator 41.54 78.20

Price Performance

Historical Comparison
BRC
BLTE

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: